Description

3-(4-Benzyl-3-Oxo-7-Trifluoromethyl-3,4-Dihydro-Quinoxalin-2-Yl)-Propionic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic quinoxaline core. This compound matters for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly those targeting specific therapeutic pathways. Pharmaceutical R&D and fine chemical manufacturers need this material for developing next-generation drugs, leveraging its unique molecular structure to create compounds with enhanced biological activity.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly in oncology and central nervous system (CNS) therapeutic areas.
• Organic Synthesis Building Block: Used in research and development for constructing complex heterocyclic molecules due to its reactive propionic acid moiety and substituted quinoxaline ring.
• Agrochemical Research: Serves as a starting material for developing new crop protection agents and herbicides, exploiting the biological activity of the quinoxaline scaffold.
• Material Science Applications: Investigated for use in the development of specialty chemicals and advanced functional materials.
• Contract Research & Development (CRO/CMO): Supplied to research organizations and contract manufacturers for custom synthesis projects and process development.

Basic Information

Product Name	3-(4-Benzyl-3-Oxo-7-Trifluoromethyl-3,4-Dihydro-Quinoxalin-2-Yl)-Propionic Acid
CAS No.	565191-92-6
Molecular Formula	C21H17F3N2O3
Molecular Weight	402.37 g/mol
Synonyms	3-[4-Benzyl-3-oxo-7-(trifluoromethyl)-3,4-dihydroquinoxalin-2-yl]propanoic acid; 2-(2-Carboxyethyl)-4-benzyl-7-trifluoromethyl-3,4-dihydro-3-oxoquinoxaline; 3-(4-Benzyl-3-oxo-7-trifluoromethyl-3,4-dihydro-2-quinoxalinyl)propionic Acid; 565191-92-6; 4-Benzyl-2-(2-carboxyethyl)-7-(trifluoromethyl)-3,4-dihydroquinoxalin-3-one; Propanoic acid, 3-[4-benzyl-3-oxo-7-(trifluoromethyl)-3,4-dihydro-2-quinoxalinyl]-
EINECS	Contact for details

Quality Control

Our 3-(4-Benzyl-3-Oxo-7-Trifluoromethyl-3,4-Dihydro-Quinoxalin-2-Yl)-Propionic Acid is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) detailing all specifications are available upon request to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to ensure optimal stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.